National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/3/2021 release of VAERS data:

This is VAERS ID 1416044



Case Details

VAERS ID: 1416044 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-06-04
Onset:2021-06-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW3143 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blindness transient, Cold sweat, Hypoaesthesia, Somnolence, Tinnitus
SMQs:, Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Glaucoma (broad), Optic nerve disorders (broad), Retinal disorders (broad), Hearing impairment (narrow), Hypoglycaemia (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Tinnitus
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021657310

Write-up: On 05Jun2021; vision loss/vision loss; recovered on 05Jun2021; tinnitus; numbness of upper arm; cold sweat; drowsiness; This is a spontaneous report from a contactable consumer (patient) received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106052350122640-Z1JMR. A 35-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unspecified route of administration on 04Jun2021 (batch/lot number EW3143 and expiry date unknown) at 35 years of age as 1st dose, single for covid-19 immunization. Medical history included tinnitus. The patient has not had symptoms associated with COVID-19, not had a COVID-19 test, was not enrolled in clinical trial. The patient''s concomitant medications were not reported. On 04Jun2021, the patient experienced drowsiness. On 05Jun2021, the patient experienced vision loss (medically significant), tinnitus, cold sweat, numbness of upper arm. The patient informed that he received the 1st jab yesterday noon (04Jun2021) and this morning at 5 am (05Jun2021), he felt numbness with his arm, on the way to bathroom he lost vision, and tinnitus simultaneously for several minutes. The patient returned to bed immediately and lie down for another several minutes with cold sweat. The patient informed that after his vision resumed, he took a paracetamol tablet (500 mg) before return to sleep. The patient did not receive any other medical treatment. The patient has not tested positive for COVID-19 since having the vaccine. The outcome of the events On 05Jun2021; vision loss/vision loss; recovered on 05Jun2021, tinnitus, cold sweat was recovered on 05Jun2021, while not recovered for the rest of the events. No follow-up attempts are possible. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1416044


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166